Device type · GXI
Probe, Radiofrequency Lesion
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GXI
Neurology
Device class
Class II
FDA decisions since 2015
22
510(k), De Novo and PMA
Adverse event reports
127
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Probe, Radiofrequency Lesion
- Product code
- GXI
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.4725
- Specialty
- Neurology & Neurosurgery
- FDA record
- Classification database entry for GXI
Latest FDA decisions
The 8 newest of 22 since 2015.
K253907 · Decided Apr 16, 2026 · 132 days after receipt
Device type: Probe, Radiofrequency Lesion (GXI) · Neurology & Neurosurgery
- STAR RF Ablation System510(k)
K251802 · Decided Feb 13, 2026 · 246 days after receipt
Device type: Probe, Radiofrequency Lesion (GXI) · Neurology & Neurosurgery
Neuroone Medical Technologies Corp.
K251243 · Decided Aug 15, 2025 · 115 days after receipt
Device type: Probe, Radiofrequency Lesion (GXI) · Neurology & Neurosurgery
19 more FDA decisions with a free account
Reports received
127
Received Nov 1, 2025 to Nov 19, 2026. Includes 4 of another or unstated type.
Malfunction reports
48
38% of reports
Injury reports
74
58% of reports
Death reports
1
0.8% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 2 | 0 | 0 |
| Jan 24 | 6 | 3 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 4 | 3 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 1 | 1 | 0 | 0 |
| Jun 24 | 3 | 0 | 0 | 0 |
| Jul 24 | 1 | 4 | 1 | 0 |
| Aug 24 | 3 | 0 | 0 | 0 |
| Sep 24 | 0 | 4 | 0 | 0 |
| Oct 24 | 2 | 1 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 4 | 0 | 0 |
| Jan 25 | 3 | 1 | 0 | 0 |
| Feb 25 | 14 | 6 | 0 | 0 |
| Mar 25 | 3 | 8 | 1 | 0 |
| Apr 25 | 1 | 8 | 0 | 0 |
| May 25 | 1 | 5 | 0 | 0 |
| Jun 25 | 7 | 4 | 0 | 0 |
| Jul 25 | 3 | 1 | 0 | 0 |
| Aug 25 | 2 | 9 | 1 | 0 |
| Sep 25 | 0 | 1 | 0 | 0 |
| Oct 25 | 3 | 2 | 0 | 0 |
| Nov 25 | 3 | 3 | 0 | 0 |
| Dec 25 | 3 | 5 | 0 | 0 |
| Jan 26 | 7 | 5 | 1 | 0 |
| Feb 26 | 2 | 3 | 0 | 0 |
| Mar 26 | 5 | 7 | 0 | 0 |
| Apr 26 | 5 | 9 | 0 | 0 |
| May 26 | 4 | 5 | 0 | 0 |
| Jun 26 | 5 | 7 | 0 | 0 |
| Jul 26 | 4 | 1 | 0 | 1 |
| Aug 26 | 3 | 7 | 0 | 2 |
| Sep 26 | 5 | 14 | 0 | 1 |
| Oct 26 | 2 | 8 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Stryker11
6 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem39
- Material Integrity Problem28
- Material Fragmentation21
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Foreign Body In Patient45
- No Clinical Signs, Symptoms or Conditions41
- Pain7
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Boston Scientific Neuromodulation Corporation
Z-2402-2026 · Started Apr 29, 2026 · Posted by FDA Jun 11, 2026
Reason given: Reusable electrodes may not meet expected performance levels.
Cause as FDA categorized it: Under Investigation by firm
Boston Scientific Neuromodulation Corporation
Z-2403-2026 · Started Apr 29, 2026 · Posted by FDA Jun 11, 2026
Reason given: Reusable electrodes may not meet expected performance levels.
Cause as FDA categorized it: Under Investigation by firm
Boston Scientific Neuromodulation Corporation
Z-2694-2026 · Started Apr 22, 2026 · Posted by FDA Jul 8, 2026
Reason given: Intraosseous nerve ablation system instruments may have sterile barrier breach of the outer tray seal, which may introduce a risk of sterility breach, and if breached could lead to severe infection.
Cause as FDA categorized it: Packaging process control
26 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.